Warning! These ASX 200 shares were just downgraded

Morgans has downgraded these shares this week. Let's find out why.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It has been a busy period with countless ASX 200 shares releasing their results.

The team at Morgans has been busy running the rule over them.

Three that haven't fared too well and have been hit with downgrades to their ratings are listed below. Here's what the broker is saying about them:

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.

Image source: Getty Images

Endeavour Group Ltd (ASX: EDV)

Morgans wasn't overly impressed with the results of this drinks giant in FY 2025, noting that it was a touch weaker than expected.

And with the recovery in liquor spending hard to predict, it has decided to downgrade this ASX 200 share to a hold rating with a trimmed price target of $4.15. It explains:

EDV's FY25 result overall was slightly weaker than expected. A decline in Retail earnings due to subdued consumer spending was partly offset by a slight improvement in Hotels earnings. Retail sales in the early part of FY26 have remained subdued while Hotels has gotten off to a solid start. We decrease FY26-28F group EBIT by between 5-6%. Our target price declines to $4.15 (from $4.35) on the back of adjustments to earnings forecasts.

With a 12-month TSR of 5%, we move to a HOLD rating (from ACCUMULATE). While retail liquor demand is expected to improve as inflation moderates and interest rates decline, the timing and extent of any uplift remains uncertain. In contrast, the outlook for Hotels is more positive with benefits from the network renewal program beginning to materialise. However, we think short-term upside for EDV's share price may be limited with the outcome of the portfolio review not expected until 2H26 and the long-term strategy remains unclear.

Pilbara Minerals Ltd (ASX: PLS)

This lithium miner delivered a result in line with expectations in FY 2025.

However, with the ASX 200 share rallying strongly recently, the broker feels that it is now fully valued. As a result, Morgans has downgraded Pilbara Minerals shares to a hold rating with a $2.30 price target. It said:

FY25 headline numbers contained no major surprises. Higher D&A than forecast and accounting treatment of some expenditure were behind the lower underlying NPAT compared to MorgansF and consensus. PLS' FY26 strategy will focus on maximising operational performance and fully realising the benefits of the Pilgangoora expansion, while maintaining cost discipline and progressing diversification initiatives at Colina (Brazil) and P-PLS (South Korea).

PLS highlighted increased demand for its product from chemical converters but cautioned lithium prices will remain volatile and subject to sharp spikes and drops. We downgrade to a HOLD rating (from BUY) following a strong share price run with an unchanged A$2.30ps Target Price.

Reece Ltd (ASX: REH)

Finally, this plumbing parts company has also been hit by a downgrade from Morgans.

It highlights its weak earnings result in FY 2025 and uncertain outlook as reasons to be cautious. Morgans has downgraded Reece's shares to a trim rating from hold with a reduced price target of $11.10. It said:

While REH's FY25 EBIT of $548m was at the bottom end of management's guidance range of $548-558m provided in late June, the outlook remains uncertain in both ANZ and the US as the company deals with a soft housing market, cost inflation, and increased competitive threats. Management anticipates a slow recovery in ANZ with a period of soft activity still to play out. In the US, the housing market is expected to be constrained for the next 12-18 months driven by persistently high mortgage rates and affordability challenges. We decrease FY26-28F group EBIT by between 10-12%. For FY26, we forecast earnings to be lower in both regions compared to a modest improvement previously.

We note however that forward visibility remains low. Our target price falls to $11.10 (from $14.80) and we downgrade our rating to TRIM (from HOLD). While we continue to view REH as a fundamentally good business with a strong culture and long track record of growth, the operating environment remains tough (particularly in the US) with further downside risk to earnings forecasts if housing conditions remain weak and competitive pressures intensify.

Motley Fool contributor James Mickleboro has positions in Endeavour Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Morgans names 2 ASX shares to buy and 1 to accumulate

What is the broker recommending investors do with these shares?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

2 ASX 200 shares to buy ahead of anticipated rally: expert

After a 9.1% drop between 27 February and 23 March, the ASX 200 reversed course last Tuesday.

Read more »

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Broker Notes

Bell Potter says this ASX 200 stock can rise 38% and pay a 6% dividend yield

Major upside and a generous dividend yield could be on offer with this name.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Is this ASX defence stock the next DroneShield?

Bell Potter thinks this stock could be the next to rocket. Let's find out why.

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Broker Notes

This ASX healthcare stock could almost double in value according to Bell Potter

The broker believes this stock is making major breakthroughs.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

a miner holds his thumb up as he holds a device in his other hand.
Resources Shares

Experts name 3 ASX mining shares to buy after March sell-off

Investors took profits amid fears the fuel crisis could impact miners' production and earnings.

Read more »